数字健康技术加强炎症性关节炎临床试验中以患者为中心的结果评估
炎症性关节炎包括类风湿关节炎、银屑病关节炎、中轴型脊柱关节炎和幼年特发性关节炎,其核心结局域中的功能能力和体力活动目前完全依赖主观自报问卷,易受回忆偏倚影响且无法捕捉时间波动。尽管基于传感器的数字健康技术在帕金森病、杜氏肌营养不良、慢性阻塞性肺疾病和心力衰竭的随机对照试验中已有应用,但尚无用于招募炎症性关节炎患者的临床试验。本文借鉴医学各领域的案例,概述开发新型基于传感器的数字健康技术衍生终点的机遇与挑战。
要点
- 炎症性关节炎核心结局域中的功能能力和体力活动目前完全依赖主观自报问卷,易受回忆偏倚影响。
- 基于传感器的数字健康技术衍生终点已在帕金森病、杜氏肌营养不良、慢性阻塞性肺疾病和心力衰竭的随机对照试验中应用。
- 目前尚无基于传感器的数字健康技术衍生终点用于招募炎症性关节炎患者的临床试验。
核心结论
- 本文概述了开发捕捉炎症性关节炎患者最相关症状和疾病表现的新型基于传感器的数字健康技术衍生终点的机遇与挑战。
研究设计与样本
- 本文为综述,借鉴医学各领域的案例研究,概述开发新型基于传感器的数字健康技术衍生终点的机遇与挑战。
主要发现
- 类风湿关节炎、银屑病关节炎、中轴型脊柱关节炎和幼年特发性关节炎均存在因关节疼痛、肿胀、僵硬及最终关节损伤而致活动能力下降的潜在可能。
- 现有核心结局域中的终点完全依赖自报问卷,捕捉患者对症状和活动的感知,具有主观性、易受回忆偏倚影响且无法捕捉随时间波动的细节。
- 基于传感器的数字健康技术衍生终点已在帕金森病、杜氏肌营养不良、慢性阻塞性肺疾病和心力衰竭的随机对照试验中应用。
- 目前尚无基于传感器的数字健康技术衍生终点用于招募炎症性关节炎患者的临床试验。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Common to all inflammatory arthritides, namely rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, and juvenile idiopathic arthritis, is a potential for reduced mobility that manifests through joint pain, swelling, stiffness, and ultimately joint damage. Across these conditions, consensus has been reached on the need to capture outcomes related to mobility, such as functional capacity and physical activity, as core domains in randomised controlled trials. Existing endpoints within these core domains rely wholly on self-reported questionnaires that capture patients' perceptions of their symptoms and activities. These questionnaires are subjective, inherently vulnerable to recall bias, and do not capture the granularity of fluctuations over time. Several early adopters have integrated sensor-based digital health technology (DHT)-derived endpoints to measure physical function and activity in randomised controlled trials for conditions including Parkinson's disease, Duchenne's muscular dystrophy, chronic obstructive pulmonary disease, and heart failure. Despite these applications, there have been no sensor-based DHT-derived endpoints in clinical trials recruiting patients with inflammatory arthritis. Borrowing from case studies across medicine, we outline the opportunities and challenges in developing novel sensor-based DHT-derived endpoints that capture the symptoms and disease manifestations most relevant to patients with inflammatory arthritis.
引用
- McGagh D, Song K, Yuan H, et al. Digital health technologies to strengthen patient-centred outcome assessment in clinical trials in inflammatory arthritis. Lancet Rheumatol. 2024. PMID: 39089297. doi:10.1016/S2665-9913(24)00186-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。